Our interests focuses in new pillar of healthcare solutions through “Advanced therapy medicinal products (ATMPs).

T-cell therapy for cancer treatment

Gene therapy for genetic diseases

Stem cell therapy for regenerative medicine

The ATMPs are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of diseases and injury.

Biogenen Scientific started its journey in 2014 as ClonGenex with its aspiration in next generation technology for life and life science. We endeavor to facilitate emerging breakthrough solutions for healthcare and biomedical research.

Our decades of experience in genome and stem cell biology brought us in an advantageous position to offer advanced modalities for unmet medical needs in blood diseases, auto-immune diseases, organ failures and tissue injuries.

We specialize in infrastructure development, process development and production of ATMPs for clinical research and patient care using cell and gene therapies.